Association between serum glucose/potassium ratio and acute kidney injury in patients with traumatic brain injury: based on MIMIC-IV database

创伤性脑损伤患者血清葡萄糖/钾比值与急性肾损伤的相关性:基于MIMIC-IV数据库

阅读:2

Abstract

BACKGROUND: Acute kidney injury (AKI) is a common complication in patients with traumatic brain injury (TBI) and is closely linked to prognosis. Although the serum glucose-to-potassium ratio (GPR) is a prognostic indicator in various diseases, its clinical significance in this specific patient population remains unexplored. METHODS: We identified patients requiring intensive care unit admission from the critical care medical information database and stratified them into quintiles based on GPR. The nonlinear relationship between GPR and AKI in TBI patients was analysed by restricted cubic splines (RCS). We conducted an exploratory subgroup analysis to investigate the differences in this association across different subgroups. Using mediation analysis, we aimed to explore the potential mediating effect of fluid balance in the development of AKI in patients with GPR and TBI. RESULTS: 1536 patients with TBI were included, of whom 1162 developed AKI. Every one unit increase in GPR increases the risk of AKI in TBI patients by 1.3% (odds ratio (OR) = 1.013; 95% confidence interval CI) = 1.004-1.024, P = 0.014). Further, RCS analysis indicated an approximately linear positive correlation between the increase in GPR and the AKI risk (P = 0.235). Subgroup analysis indicated that both patients with abnormal serum glucose and those with normal potassium levels showed a significant positive correlation with AKI risk (OR>1, P < 0.05). Fluid balance potentially mediated the association between GPR and TBI-induced AKI in part, with a mediating effect of 4.49 × 10(-4) (95% CI = 2.04 × 10(-4)-1.18 × 10(-3), P < 0.001). CONCLUSIONS: GPR is significantly associated with AKI risk in TBI patients, which may be mediated by FB. We identified GPR as a new biomarker for assessing AKI risk in TBI patients, thereby offering fresh insights into prevention and treatment for this population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。